Weis Markets Q2 profit falls as pharmacy pricing headwinds weigh
Weis Markets Q2 profit falls as pharmacy pricing headwinds weigh
Overview
US food retailer's Q2 revenue rose 4.6% yr/yr, comparable store sales up 2.3%
Q2 net income declined 9.6% yr/yr, EPS fell to $0.92 from $0.96
Pharmacy revenue growth was hurt by Inflation Reduction Act Medicare pricing headwinds
Outlook
Company says customers remain focused on affordability and value, impacting shopping behavior
Weis Markets is increasing investment in promotions and targeted loyalty marketing
Result Drivers
PROMOTIONS AND LOYALTY MARKETING - Co said increased investment in promotions and targeted loyalty marketing supported sales growth
PHARMACY PRICING PRESSURE - Co said pharmacy revenue growth was hurt by Medicare pricing headwinds from the Inflation Reduction Act
VALUE-FOCUSED SHOPPING - Co said customers remain focused on affordability and value, impacting how they shop
Company press release: ID:nPnb3sg7ra
Key Details
Metric | Beat/Miss | Actual | Consensus Estimate |
Q2 Sales |
| $1.28 bln |
|
Q2 EPS |
| $0.92 |
|
Q2 Net Income |
| $22.86 mln |
|
Reuters Recommended Reads
Aug 3 - Tyson Foods cuts profit forecast as tight US cattle supplies hurt beef business
Aug 3 - Whole Foods ban on Black Lives Matter apparel was lawful, US labor board rules
Aug 4 - Kimberly-Clark cuts annual forecasts as China quality claims hurt diaper sales
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Recent news on Weis Markets
See all newsWeis Markets Q2 profit falls as pharmacy pricing headwinds weigh
Regional grocer Weis Markets' Q1 net income rises
Weis Markets Q4 revenue rises but net income falls
Brief: Weis Markets Reports Delay Of Annual Report On Form 10-K For FY Ended December 27
Brief: Weis Markets Says Financial Statements From 2022 To 2025 Not Reliable